Anokion

Anokion

Biotechnology Research

Cambridge, Massachusetts 4,232 followers

Restoring normal IMMUNE TOLERANCE to treat autoimmune disease

About us

Anokion SA is a Swiss biotechnology company that aims to make a meaningful difference in the lives of patients suffering from autoimmune diseases by restoring normal immune tolerance. The company is focused on both prevalent and rare autoimmune diseases, including celiac disease, multiple sclerosis and type 1 diabetes. Anokion’s distinct approach leverages the company’s immune-based platform, which targets natural pathways in the liver to restore immune tolerance and address the underlying cause of autoimmune disease.

Industry
Biotechnology Research
Company size
11-50 employees
Headquarters
Cambridge, Massachusetts
Type
Privately Held
Specialties
Immunoengineering, Protein engineering, Biologics, and Autoimmune diseases

Locations

Employees at Anokion

Similar pages

Browse jobs

Funding